Botox 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FBSEH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,034
Award facts
- Contract value 100% obligated
- $23,033.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,033.76 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for BOTOX 100 Unit Vials. The delivery order, issued on January 27, 2026, with an ultimate completion date of February 18, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award was issued without subcontractors and represents a routine procurement action within DMS Pharmaceutical Group's ongoing supply relationship with the federal government.
This delivery order falls under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The parent IDC, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for comprehensive pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group's established performance on numerous prior delivery orders positions it as a critical pharmaceutical supplier within the federal military medical supply chain, with the company's product portfolio encompassing branded and generic medications, biologics, vaccines, and specialty pharmaceuticals.
Quick answers
Who was awarded contract SPE2DR26FBSEH?
SPE2DR26FBSEH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FBSEH worth?
The government has obligated $23,034 on SPE2DR26FBSEH.
Is contract SPE2DR26FBSEH an order under another contract?
Yes. SPE2DR26FBSEH is a delivery order under SPE2DR25D9158, an indefinite delivery contract.
Was contract SPE2DR26FBSEH competed?
The extent of competition for SPE2DR26FBSEH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award